Thomas Celona - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Thomas Celona's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Thomas Celona
Verified
Associate Editor, Cancer Today
Philadelphia
Beats
public health and sanitation cybersecurityeducation transportation and disinformation
Content
By Thomas Celona Verified| Cancer Today Verified Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. A surgical approach could spare people with localized prostate cancer from experiencing sexual side effects, according to study results presented at the 2025 European Association of Urology Congress in Madrid and simultaneously published in the Lancet Oncology.
Cancer Today’s Spring 2025 Issue: How Liquid Biopsies Can Guide Treatment Decisions, Extending Survival in Treatment-resistant Breast Cancer, and More
By Thomas Celona Verified| American Association for Cancer Research@ After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he started radiation therapy. His oncologist told him he might be eligible for targeted therapy, but he would have to wait four to six weeks for results from tumor tissue testing. The possibility of targeted therapy sounded promising, but the wait did not. “When you get diagnosed with cancer, it’s like, get me on some kind of treatment,” Schumpert says.
By Thomas Celona Verified| Cancer Today Verified Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. A surgical approach could spare people with localized prostate cancer from experiencing sexual side effects, according to study results presented at the 2025 European Association of Urology Congress in Madrid and simultaneously published in the Lancet Oncology.
Company Info
Cancer Today
Published quarterly by the American Association for Cancer Research, Cancer Today is the authoritative resource for cancer patients, survivors, and their family members and friends. In every issue, Cancer Today offers information and inspiration as you face the challenges of diagnosis, treatment, survivorship or caregiving.‬ Cancer Today is the authoritative resource for cancer patients, survivors and caregivers who are seeking information and inspiration as they or their loved ones face diagnosis, treatment and life after cancer. Cancer Today guides readers through every step of the cancer journey, empowering them with reliable reporting on the latest advances in cancer research; insider looks at the people driving progress against cancer; practical advice for living life as a cancer patient or survivor; guidance on being an active partner in one's treatment; candid stories about how patients, survivors and caregivers are dealing with the disease; and thoughtful examination of efforts to overcome obstacles to quality cancer care and quality of life.‬
'+1 215-440-9300
Founded: 1996